Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Charles River Laboratories acquires Citoxlab

Charles River Laboratories, Inc. has announced its acquisition of Citoxlab Group. The deal is valued at €448 million ($510 million). Based in France, Citoxlab Group is a contract research laboratory that provides pre-clinical services to pharmaceutical, biotechnology, chemical, cosmetics, medical devices, and food companies. US-based Charles River is a provider of essential products and services to pharmaceutical and biotechnology companies, government agencies and academic institutions. Evercore provided financial advice to Charles River on the transaction. Axinn, Veltrop & Harkrider LLP acted as antitrust counsel and Goodwin Procter LLP provided legal counsel to Citoxlab.

Tags:

Mergers & Acquisitions,M&A ,M&A deals